Fundz

Fundz Deep Dive

Everything you need to win Abolis Biotechnologies — in one platform.

Who to reach, what to say, and why now on Abolis Biotechnologies — plus every funding round, exec hire, and M&A move that follows, each with the verified contact and the outreach written for you.

Get the full Deep Dive on Abolis Biotechnologies — free.

One free Deep Dive, emailed to you. No spam; unsubscribe anytime.

Ready now? Choose your plan · Request a demo · Sign in

Engage writes the reply
Grounded in signals no one else has — tuned to their persona.
Signals no one else has
UCC liens, benefit plans, 13F holdings, permits, exec moves — fused.
Verified contact + click-to-call
The decision-maker’s email and mobile — dial in-browser.

French biotech Abolis Biotechnologies raises €35M in a funding round led by BOLD and Evonik Venture Capital to boost its biomanufacturing operations and microbial ecosystem engineering.

PRIVATESep 12, 2024•over 1 year ago

Amount Raised

€35 Million

EvryBiotechnology

Investors

LibersetIcos CapitalClay CapitalDeep Tech & Climate FondsEvonik Venture CapitalBold

Description

Abolis Biotechnologies has secured €35 million in a financing round aimed at scaling its biomanufacturing operations and accelerating business development. The investment will support the company's focus on developing its own product line and expanding its Microbiome Studio activities.

Company Information

Company

Abolis Biotechnologies

Location

Evry, Ile De France, France

About

Abolis Biotechnologies is a French company delivering high-impact innovations in biotechnologies aimed at supporting industries in transitioning to a more sustainable production model. They build a better future in collaboration with Nature by providing tailor-made industrial solutions based on natural and modified micro-organisms. Their efforts focus on scaling biomanufacturing operations, developing product lines, and engineering microbial ecosystems.

Related People

Suggested for you
1 contact

Choose your plan to reveal verified contacts

Predictive Intelligence
Strategic

ML-powered predictions for Abolis Biotechnologies's next move

Learn about Strategic plan

Funding Insights

Based on industry data
VC-backed spending patterns
VC-backed companies spend 89% more on sales and 100% more on marketing than bootstrapped peers
Tech investment trends
83% of B2B companies plan digital investments, with 79% prioritizing customer experience tech

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals — including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications — based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 200,000+ companies. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.

Watching Abolis Biotechnologies? See every signal — funding, hires, M&A, contracts, sentiment.

Request a demoChoose your plan